Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04762615
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2021-02-02
Brief Title:
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Sponsor:
Wroclaw Medical University
Organization:
Wroclaw Medical University
Study Overview
Official Title:
Impact of the Immunosuppressive Treatment X-ray Exposition and Renal Pathology on Ovarian Reserve in Young Women
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aging renal pathology eg SLE ADPKD X-ray exposition and pharmacological treatments especially previous strong immunosuppression may negatively influence the ovarian reserve in childbearing age women Anti-Müllerian hormone AMH is regarded as biomarker for ovarian reserve
Every female with renal disease regularly menstruating that met exclusion criteria could have participated The aim was to assess ovarian reserve in female patients with normal menstrual cycle and kidney disease including kidney transplant recipients
Every female with renal disease regularly menstruating that met exclusion criteria could have participated The aim was to assess ovarian reserve in female patients with normal menstrual cycle and kidney disease including kidney transplant recipients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None